Medicortex Finland Oy: Clinical Trial Extended for Detection of Mild Traumatic Brain Injury
New Biomarker Has Potential For Sideline Diagnosis of Traumatic Brain Injury
Dr. Harel interviewed by MedicalResearch.com
Demand for Diagnostic for Early Detection of Brain Injury After Surprising Study On NFL Players Brains And CTE
Medicortex raises EUR 140K
Aivovammojen biomarkkeritesti etenee suunnitellusti
Featuring in Aivoitus 2/2017. The journal of the Finnish Brain Injury Association.
Medicortex has completed the collection of clinical samples in collaboration with Turku University Hospital (Tyks).